Hysteroscopic treatments for endometrial malignancies and premalignancies: state of the art
Autor: | Ilker Kahramanoglu |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
media_common.quotation_subject Fertility Hysteroscopy Atypical hyperplasia Endometrium medicine Humans Stage (cooking) media_common Gynecology medicine.diagnostic_test business.industry Endometrial cancer Fertility Preservation medicine.disease Endometrial Neoplasms Endometrial hyperplasia Menopause stomatognathic diseases Endometrial Hyperplasia Hormonal therapy Female Surgery business |
Zdroj: | Minimally Invasive Therapy & Allied Technologies. 30:272-277 |
ISSN: | 1365-2931 1364-5706 |
DOI: | 10.1080/13645706.2021.1919904 |
Popis: | Endometrioid endometrial cancer (EEC) is the most common gynecologic malignancy worldwide. One in four cases will be diagnosed before menopause. Endometrial atypical hyperplasia (EAH) is a precursor of endometrial cancer and tends to occur at a young age. Those who have early stage, grade 1 EEC or EAH and wish to preserve their fertility can be managed with hormonal therapy. Hysteroscopic treatment in addition to progestin therapy has been used more commonly in the last decade. Herein, a review of available data on hysteroscopic treatment in EEC and EAH is presented. |
Databáze: | OpenAIRE |
Externí odkaz: |
Pro tento záznam nejsou dostupné žádné jednotky.